$MNKD
MANNKIND CORP Stock $mnkd

$mnkd Overview Financials Valuation SEC Filings Company Website

2016 Q1 Form 10-Q Financial Statement

#000119312516583791 Filed on May 09, 2016

Income Statement

Concept	2016 Q1	2015 Q1
Revenue	$0.00	$0.00
YoY Change
Cost Of Revenue	$5.168M	$1.900M
YoY Change	172.0%
Gross Profit	-$5.168M	-$1.900M
YoY Change	172.0%
Gross Profit Margin
Selling, General & Admin	$7.351M	$10.50M
YoY Change	-29.99%	-30.92%
% of Gross Profit
Research & Development	$5.130M	$9.377M
YoY Change	-45.29%	-64.19%
% of Gross Profit
Depreciation & Amortization	$600.0K	$2.300M
YoY Change	-73.91%	-8.0%
% of Gross Profit
Operating Expenses	$20.01M	$21.74M
YoY Change	-7.94%	-47.51%
Operating Profit	-$20.01M	-$21.74M
YoY Change	-7.94%	-47.51%
Interest Expense	-$4.900M	-$10.30M
YoY Change	-52.43%	114.58%
% of Operating Profit
Other Income/Expense, Net	-$4.860M	$1.413M
YoY Change	-443.95%	-123.99%
Pretax Income	-$24.87M	-$30.66M
YoY Change	-18.87%	-41.11%
Income Tax	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$24.87M	-$30.66M
YoY Change	-18.87%	-41.11%
Net Earnings / Revenue
Basic Earnings Per Share	-$0.29
Diluted Earnings Per Share	-$0.29	-$383.3K
COMMON SHARES
Basic Shares Outstanding	85.77M	408.8M shares
Diluted Shares Outstanding	85.77M

Balance Sheet

Concept	2016 Q1	2015 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$27.70M	$120.8M
YoY Change	-77.07%	237.43%
Cash & Equivalents	$27.65M	$120.8M
Short-Term Investments
Other Short-Term Assets	$16.30M	$16.40M
YoY Change	-0.61%	355.56%
Inventory		$16.79M
Prepaid Expenses
Receivables	$144.0K	$4.282M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$44.14M	$158.3M
YoY Change	-72.11%	301.76%
LONG-TERM ASSETS
Property, Plant & Equipment	$48.03M	$193.5M
YoY Change	-75.17%	9.71%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$1.096M	$2.027M
YoY Change	-45.93%	-75.97%
Total Long-Term Assets	$49.13M	$201.7M
YoY Change	-75.65%	8.95%
TOTAL ASSETS
Total Short-Term Assets	$44.14M	$158.3M
Total Long-Term Assets	$49.13M	$201.7M
Total Assets	$93.27M	$360.0M
YoY Change	-74.09%	60.33%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$582.0K	$3.302M
YoY Change	-82.37%	-9.24%
Accrued Expenses	$8.077M	$12.38M
YoY Change	-34.76%	-17.49%
Deferred Revenue
YoY Change
Short-Term Debt	$75.00M	$73.40M
YoY Change	2.18%	183.4%
Long-Term Debt Due		$99.60M
YoY Change
Total Short-Term Liabilities	$249.2M	$380.8M
YoY Change	-34.55%	755.34%
LONG-TERM LIABILITIES
Long-Term Debt	$146.0M	$49.50M
YoY Change	194.95%	-66.6%
Other Long-Term Liabilities	$15.95M	$26.78M
YoY Change	-40.45%	87.02%
Total Long-Term Liabilities	$15.95M	$26.78M
YoY Change	-40.45%	87.02%
TOTAL LIABILITIES
Total Short-Term Liabilities	$249.2M	$380.8M
Total Long-Term Liabilities	$15.95M	$26.78M
Total Liabilities	$466.7M	$457.1M
YoY Change	2.12%	120.78%
SHAREHOLDERS EQUITY
Retained Earnings	-$2.888B	-$2.525B
YoY Change	14.36%
Common Stock	$2.515B	$2.428B
YoY Change	3.55%	2.64%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$373.5M	-$97.03M
YoY Change
Total Liabilities & Shareholders Equity	$93.27M	$360.0M
YoY Change	-74.09%	60.33%

Cashflow Statement

Concept	2016 Q1	2015 Q1
OPERATING ACTIVITIES
Net Income	-$24.87M	-$30.66M
YoY Change	-18.87%	-41.11%
Depreciation, Depletion And Amortization	$600.0K	$2.300M
YoY Change	-73.91%	-8.0%
Cash From Operating Activities	-$30.76M	$3.020M
YoY Change	-1118.54%	-108.16%
INVESTING ACTIVITIES
Capital Expenditures	$1.144M	$4.203M
YoY Change	-72.78%	198.3%
Acquisitions
YoY Change
Other Investing Activities	$20.00K
YoY Change
Cash From Investing Activities	-$1.130M	-$4.200M
YoY Change	-73.1%	197.87%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	460.0K	1.190M
YoY Change	-61.34%	-64.69%
NET CHANGE
Cash From Operating Activities	-30.76M	3.020M
Cash From Investing Activities	-1.130M	-4.200M
Cash From Financing Activities	460.0K	1.190M
Net Change In Cash	-31.43M	10.00K
YoY Change	-314400.0%	-100.03%
FREE CASH FLOW
Cash From Operating Activities	-$30.76M	$3.020M
Capital Expenditures	$1.144M	$4.203M
Free Cash Flow	-$31.90M	-$1.183M
YoY Change	2596.87%	-96.92%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2016Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	429161347	shares
CY2015Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	120844000
CY2015Q3	mnkd	Common Stock Loaned Under Share Lending Agreement Shares CommonStockLoanedUnderShareLendingAgreementShares	9000000	shares
CY2016Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2016Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	550000000	shares
CY2016Q1	us-gaap	Ownshare Lending Arrangement Shares Issued OwnshareLendingArrangementSharesIssued	9000000	shares
CY2016Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	429138685	shares
CY2016Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2016Q1	us-gaap	Preferred Stock Value PreferredStockValue
CY2016Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2193000
CY2016Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2888102000
CY2016Q1	us-gaap	Stockholders Equity StockholdersEquity	-373464000
CY2016Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	93272000
CY2016Q1	us-gaap	Purchase Obligation Due In Fourth Year PurchaseObligationDueInFourthYear	23300000
CY2016Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	134935000
CY2016Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-19000
CY2016Q1	us-gaap	Other Deferred Credits Current OtherDeferredCreditsCurrent	17680000
CY2016Q1	us-gaap	Purchase Obligation PurchaseObligation	98500000
CY2016Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	582000
CY2016Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	48033000
CY2016Q1	us-gaap	Assets Current AssetsCurrent	44143000
CY2016Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	27653000
CY2016Q1	us-gaap	Assets Assets	93272000
CY2016Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2807000
CY2016Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	144000
CY2016Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2016Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2016Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	429138685	shares
CY2016Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2016Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2016Q1	us-gaap	Liabilities Current LiabilitiesCurrent	249211000
CY2016Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	5685000
CY2016Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	119430000
CY2016Q1	us-gaap	Notes Payable Related Parties Noncurrent NotesPayableRelatedPartiesNoncurrent	49521000
CY2016Q1	us-gaap	Loss Contingency Accrual Carrying Value Noncurrent LossContingencyAccrualCarryingValueNoncurrent	68835000
CY2016Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	8077000
CY2016Q1	us-gaap	Line Of Credit Facility Remaining Borrowing Capacity LineOfCreditFacilityRemainingBorrowingCapacity	30100000
CY2016Q1	us-gaap	Liabilities Liabilities	466736000
CY2016Q1	us-gaap	Purchase Obligation Due In Second Year PurchaseObligationDueInSecondYear	23300000
CY2016Q1	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	27618000
CY2016Q1	us-gaap	Purchase Obligation Due In Third Year PurchaseObligationDueInThirdYear	23300000
CY2016Q1	us-gaap	Purchase Obligation Due In Next Twelve Months PurchaseObligationDueInNextTwelveMonths	28800000
CY2016Q1	us-gaap	Common Stock Value CommonStockValue	4290000
CY2016Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	2510367000
CY2016Q1	us-gaap	Interest Payable Current InterestPayableCurrent	199000
CY2016Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	15946000
CY2016Q1	us-gaap	Other Long Term Debt Current OtherLongTermDebtCurrent	75010000
CY2016Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	167463000
CY2016Q1	us-gaap	Deferred Costs Current DeferredCostsCurrent	13539000
CY2016Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1096000
CY2016Q1	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	26000000
CY2016Q1	mnkd	Available Borrowings Under Loan Agreement AvailableBorrowingsUnderLoanAgreement	0
CY2016Q1	mnkd	Purchase Obligation Current PurchaseObligationCurrent	12927000
CY2016Q1	mnkd	Purchase Obligation Noncurrent PurchaseObligationNoncurrent	55605000
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	120841000
CY2015Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2015Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	550000000	shares
CY2015Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	428670943	shares
CY2015Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2015Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2015Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	428670943	shares
CY2015Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2015Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2015Q4	us-gaap	Liabilities Current LiabilitiesCurrent	268319000
CY2015Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	5662000
CY2015Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	119513000
CY2015Q4	us-gaap	Notes Payable Related Parties Noncurrent NotesPayableRelatedPartiesNoncurrent	49521000
CY2015Q4	us-gaap	Loss Contingency Accrual Carrying Value Noncurrent LossContingencyAccrualCarryingValueNoncurrent	62371000
CY2015Q4	us-gaap	Construction Payable Current ConstructionPayableCurrent	238000
CY2015Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	7929000
CY2015Q4	us-gaap	Liabilities Liabilities	476741000
CY2015Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	27613000
CY2015Q4	us-gaap	Common Stock Value CommonStockValue	4287000
CY2015Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	2508633000
CY2015Q4	us-gaap	Interest Payable Current InterestPayableCurrent	615000
CY2015Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	15225000
CY2015Q4	us-gaap	Other Long Term Debt Current OtherLongTermDebtCurrent	74582000
CY2015Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	140231000
CY2015Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-20000
CY2015Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2015Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2015Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1414000
CY2015Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2863229000
CY2015Q4	us-gaap	Stockholders Equity StockholdersEquity	-350329000
CY2015Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	126412000
CY2015Q4	us-gaap	Other Deferred Credits Current OtherDeferredCreditsCurrent	17503000
CY2015Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	15599000
CY2015Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	48749000
CY2015Q4	us-gaap	Assets Current AssetsCurrent	76654000
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	59074000
CY2015Q4	us-gaap	Assets Assets	126412000
CY2015Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4018000
CY2015Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	23000
CY2015Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	168262000
CY2015Q4	us-gaap	Deferred Costs Current DeferredCostsCurrent	13539000
CY2015Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1009000
CY2015Q4	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	55800000
CY2015Q4	mnkd	Purchase Obligation Current PurchaseObligationCurrent	12475000
CY2015Q4	mnkd	Purchase Obligation Noncurrent PurchaseObligationNoncurrent	53692000
CY2014Q3	us-gaap	Long Term Purchase Commitment Amount LongTermPurchaseCommitmentAmount	120100000
CY2015Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	710000
CY2015Q1	us-gaap	Manufacturing Costs ManufacturingCosts	1882000
CY2015Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-4182000
CY2015Q1	us-gaap	Share Based Compensation ShareBasedCompensation	2003000
CY2015Q1	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-4203000
CY2015Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-10660000
CY2015	us-gaap	Impairment Charge On Reclassified Assets ImpairmentChargeOnReclassifiedAssets	140400000
CY2015Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	45171595	shares
CY2015Q1	us-gaap	Construction In Progress Expenditures Incurred But Not Yet Paid ConstructionInProgressExpendituresIncurredButNotYetPaid	1094000
CY2015Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2988000
CY2015Q1	us-gaap	Operating Expenses OperatingExpenses	21738000
CY2015Q1	mnkd	Proceeds From Issuance Of Common Stock And Warrants Net ProceedsFromIssuanceOfCommonStockAndWarrantsNet	6168000
CY2015Q1	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	3020000
CY2015Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.08
CY2015Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	398916000	shares
CY2015Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	872000
CY2015Q1	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	6251000
CY2015Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-30665000
CY2015Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4203000
CY2015Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1413000
CY2015Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-21738000
CY2015Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	7119000
CY2015Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-30658000
CY2015Q1	us-gaap	Sales Revenue Net SalesRevenueNet	0
CY2015Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	3000
CY2015Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	762000
CY2015Q1	us-gaap	Interest Paid InterestPaid	4749000
CY2015Q1	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	-46154000
CY2015Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-3831000
CY2015Q1	us-gaap	Net Income Loss NetIncomeLoss	-30658000
CY2015Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	7000
CY2015Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-7000
CY2015Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-7000
CY2015Q1	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	1186000
CY2015Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2300000
CY2015Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
CY2015Q1	us-gaap	Paid In Kind Interest PaidInKindInterest	33000
CY2015Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10479000
CY2015Q1	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	9377000
CY2015Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	7050000
CY2015Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	3000
CY2015Q1	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	714000
CY2015Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	9622000
CY2015Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2003000
CY2015Q1	mnkd	Milestone Payments MilestonePayments	4220000
CY2016Q1	dei	Document Type DocumentType	10-Q
CY2016Q1	us-gaap	Revenue Recognition Deferred Revenue RevenueRecognitionDeferredRevenue	<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 12pt"> <strong><em>Deferred product costs from collaboration —</em></strong> Deferred product costs represent the costs of product manufactured and shipped to Sanofi, not to exceed the amount of deferred product sales related to the collaboration, for which recognition of revenue has been deferred. Given that the costs of inventory delivered to a customer, but for which revenue may not yet be recognized, meet both the definition and characteristics of an “asset” and the Company believes that it is probable that the amount of future revenue will exceed the amount of deferred costs (i.e., the asset would be realizable through the recognition of probable future income), the Company has elected to account for the deferred costs related to the product sold to Sanofi as an asset and carry forward to future periods until the related revenue is recognized.</p> </div>
CY2016Q1	dei	Trading Symbol TradingSymbol	MNKD
CY2016Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000899460
CY2016Q1	dei	Document Period End Date DocumentPeriodEndDate	2016-03-31
CY2016Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2016Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	32280590	shares
CY2016Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2016Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P3Y
CY2016Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2016Q1	us-gaap	Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures	2364200	shares
CY2016Q1	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-30758000
CY2016Q1	us-gaap	Stock Issued During Period Shares Share Based Compensation StockIssuedDuringPeriodSharesShareBasedCompensation	4920267	shares
CY2016Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.06
CY2016Q1	dei	Entity Registrant Name EntityRegistrantName	MANNKIND CORP
CY2016Q1	dei	Amendment Flag AmendmentFlag	false
CY2016Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-24873000
CY2016Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	428858000	shares
CY2016Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2016
CY2016Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	86000
CY2016Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-24872000
CY2016Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1144000
CY2016Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	67000
CY2016Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-20013000
CY2016Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-31421000
CY2016Q1	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	721000
CY2016Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	4221000
CY2016Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1273000
CY2016Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	721000
CY2016Q1	us-gaap	Manufacturing Costs ManufacturingCosts	7532000
CY2016Q1	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	464000
CY2016Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	600000
CY2016Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
CY2016Q1	us-gaap	Paid In Kind Interest PaidInKindInterest	1168000
CY2016Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7351000
CY2016Q1	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	5130000
CY2016Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	177000
CY2016Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	17000
CY2016Q1	us-gaap	Sales Revenue Net SalesRevenueNet	0
CY2016Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	15000
CY2016Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	3000
CY2016Q1	us-gaap	Interest Paid InterestPaid	2713000
CY2016Q1	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	121000
CY2016Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1211000
CY2016Q1	us-gaap	Net Income Loss NetIncomeLoss	-24873000
CY2016Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-696000
CY2016Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	1000
CY2016Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	1000
CY2016Q1	us-gaap	Construction In Progress Expenditures Incurred But Not Yet Paid ConstructionInProgressExpendituresIncurredButNotYetPaid	558000
CY2016Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1023000
CY2016Q1	us-gaap	Operating Expenses OperatingExpenses	20013000
CY2016Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-14799000
CY2016Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1273000
CY2016Q1	us-gaap	Foreign Currency Transaction Loss Before Tax ForeignCurrencyTransactionLossBeforeTax	2364000
CY2016Q1	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-1127000
CY2016Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	488000
CY2016Q1	mnkd	Longterm Purchase Commitment Renewal Time Period LongtermPurchaseCommitmentRenewalTimePeriod	P2Y
CY2016Q1	mnkd	Long Term Purchase Commitment Expiration Date LongTermPurchaseCommitmentExpirationDate	2019-12-31
CY2016Q1	mnkd	Long Term Purchase Commitment Cancellation Fees LongTermPurchaseCommitmentCancellationFees	5200000
CY2016Q1	mnkd	Proceeds From Issuance Of Common Stock And Warrants Net ProceedsFromIssuanceOfCommonStockAndWarrantsNet	467000

Files In Submission

Name	View Source	Status
0001193125-16-583791-index-headers.html	Edgar Link	pending
0001193125-16-583791-index.html	Edgar Link	pending
0001193125-16-583791.txt	Edgar Link	pending
0001193125-16-583791-xbrl.zip	Edgar Link	pending
d162923d10q.htm	Edgar Link	pending
d162923dex31.htm	Edgar Link	pending
d162923dex32.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
mnkd-20160331.xml	Edgar Link	completed
mnkd-20160331.xsd	Edgar Link	pending
mnkd-20160331_cal.xml	Edgar Link	unprocessable
mnkd-20160331_def.xml	Edgar Link	unprocessable
mnkd-20160331_lab.xml	Edgar Link	unprocessable
mnkd-20160331_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MNKD
MANNKIND CORP Stock $mnkd

2016 Q1 Form 10-Q Financial Statement

#000119312516583791 Filed on May 09, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MNKD MANNKIND CORP Stock $mnkd

2016 Q1 Form 10-Q Financial Statement

#000119312516583791 Filed on May 09, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MNKD
MANNKIND CORP Stock $mnkd